W. Scott Gallichan

1.4k total citations
14 papers, 1.2k citations indexed

About

W. Scott Gallichan is a scholar working on Epidemiology, Genetics and Immunology. According to data from OpenAlex, W. Scott Gallichan has authored 14 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Genetics and 8 papers in Immunology. Recurrent topics in W. Scott Gallichan's work include Herpesvirus Infections and Treatments (6 papers), Virus-based gene therapy research (5 papers) and T-cell and B-cell Immunology (5 papers). W. Scott Gallichan is often cited by papers focused on Herpesvirus Infections and Treatments (6 papers), Virus-based gene therapy research (5 papers) and T-cell and B-cell Immunology (5 papers). W. Scott Gallichan collaborates with scholars based in Canada, United States and United Kingdom. W. Scott Gallichan's co-authors include Kenneth L. Rosenthal, Frank L. Graham, K L Rosenthal, Nora Sarvetnick, Heather L. Davis, Michael J. McCluskie, David C. Johnson, Balaji Balasa, Joanna D. Davies and Jack Gauldie and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Diabetes.

In The Last Decade

W. Scott Gallichan

14 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Scott Gallichan Canada 13 698 486 322 208 191 14 1.2k
Yuk‐Ying S. Pang United States 13 504 0.7× 578 1.2× 218 0.7× 206 1.0× 93 0.5× 15 1.1k
D R Lowy United States 9 551 0.8× 1.2k 2.5× 326 1.0× 248 1.2× 79 0.4× 12 1.5k
B. O'Neil United Kingdom 20 556 0.8× 952 2.0× 380 1.2× 227 1.1× 54 0.3× 27 1.5k
S. Ghim United States 11 343 0.5× 669 1.4× 192 0.6× 125 0.6× 65 0.3× 18 879
Ludwig Deml Germany 23 765 1.1× 431 0.9× 195 0.6× 523 2.5× 268 1.4× 53 1.5k
R Ahmed United States 7 985 1.4× 524 1.1× 156 0.5× 111 0.5× 188 1.0× 7 1.4k
L A Borenstein United States 15 246 0.4× 422 0.9× 155 0.5× 120 0.6× 95 0.5× 20 806
Daniel C. Freed United States 25 914 1.3× 1.0k 2.1× 230 0.7× 361 1.7× 425 2.2× 47 2.0k
P Mavromara-Nazos United States 11 228 0.3× 964 2.0× 299 0.9× 196 0.9× 43 0.2× 12 1.1k
Sam Hou United States 22 1.9k 2.7× 800 1.6× 147 0.5× 219 1.1× 332 1.7× 35 2.5k

Countries citing papers authored by W. Scott Gallichan

Since Specialization
Citations

This map shows the geographic impact of W. Scott Gallichan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Scott Gallichan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Scott Gallichan more than expected).

Fields of papers citing papers by W. Scott Gallichan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Scott Gallichan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Scott Gallichan. The network helps show where W. Scott Gallichan may publish in the future.

Co-authorship network of co-authors of W. Scott Gallichan

This figure shows the co-authorship network connecting the top 25 collaborators of W. Scott Gallichan. A scholar is included among the top collaborators of W. Scott Gallichan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Scott Gallichan. W. Scott Gallichan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Gallichan, W. Scott, et al.. (2001). Intranasal Immunization with CpG Oligodeoxynucleotides as an Adjuvant Dramatically Increases IgA and Protection Against Herpes Simplex Virus-2 in the Genital Tract. The Journal of Immunology. 166(5). 3451–3457. 186 indexed citations
2.
Braciak, T A, W. Scott Gallichan, Frank L. Graham, et al.. (2000). Recombinant adenovirus vectors expressing interleukin‐5 and ‐6 specifically enhance mucosal immunoglobulin A responses in the lung. Immunology. 101(3). 388–396. 15 indexed citations
3.
Gallichan, W. Scott, Balaji Balasa, Joanna D. Davies, & Nora Sarvetnick. (1999). Pancreatic IL-4 Expression Results in Islet-Reactive Th2 Cells That Inhibit Diabetogenic Lymphocytes in the Nonobese Diabetic Mouse. The Journal of Immunology. 163(3). 1696–1703. 74 indexed citations
4.
Gallichan, W. Scott & Kenneth L. Rosenthal. (1998). Long‐Term Immunity and Protection against Herpes Simplex Virus Type 2 in the Murine Female Genital Tract after Mucosal but Not Systemic Immunization. The Journal of Infectious Diseases. 177(5). 1155–1161. 119 indexed citations
5.
Gallichan, W. Scott, Tal Kafri, Troy Krahl, Inder M. Verma, & Nora Sarvetnick. (1998). Lentivirus-Mediated Transduction of Islet Grafts with Interleukin 4 Results in Sustained Gene Expression and Protection from Insulitis. Human Gene Therapy. 9(18). 2717–2726. 90 indexed citations
6.
Rosenthal, Kenneth L. & W. Scott Gallichan. (1997). Challenges for vaccination against sexually-transmitted diseases: induction and long-term maintenance of mucosal immune responses in the female genital tract. Seminars in Immunology. 9(5). 303–314. 50 indexed citations
7.
Gallichan, W. Scott & Kenneth L. Rosenthal. (1996). Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization.. The Journal of Experimental Medicine. 184(5). 1879–1890. 208 indexed citations
8.
9.
Serreze, David, Edward H. Leiter, Gregory J. Christianson, et al.. (1996). MHC Class I-Mediated Antigen Presentation and Induction of CD8+ Cytotoxic T-Cell Responses in Autoimmune Diabetes-Prone NOD Mice. Diabetes. 45(7). 902–908. 22 indexed citations
10.
11.
Bramson, Jonathan L., Mary Hitt, W. Scott Gallichan, et al.. (1996). Construction of a Double Recombinant Adenovirus Vector Expressing a Heterodimeric Cytokine: In Vitro and In Vivo Production of Biologically Active Interleukin-12. Human Gene Therapy. 7(3). 333–342. 94 indexed citations
12.
13.
Gallichan, W. Scott, David C. Johnson, Frank L. Graham, & K L Rosenthal. (1995). Mucosal immunization with a recombinant adenovirus vector induces local and systemic immunity and protection from herpes simplex virus.. PubMed. 371B. 1581–5. 8 indexed citations
14.
Gallichan, W. Scott, David C. Johnson, Frank L. Graham, & K L Rosenthal. (1993). Mucosal Immunity and Protection after Intranasal Immunization with Recombinant Adenovirus Expressing Herpes Simplex Virus Glycoprotein B. The Journal of Infectious Diseases. 168(3). 622–629. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuk‐Ying S. Pang Breakdown of academic impact, for papers by D R Lowy Breakdown of academic impact, for papers by B. O'Neil Breakdown of academic impact, for papers by S. Ghim Breakdown of academic impact, for papers by Ludwig Deml Breakdown of academic impact, for papers by R Ahmed Breakdown of academic impact, for papers by L A Borenstein Breakdown of academic impact, for papers by Daniel C. Freed Breakdown of academic impact, for papers by P Mavromara-Nazos Breakdown of academic impact, for papers by Sam Hou
Rankless by CCL
2026